Study Finds No Difference Between Acute Kidney Injury Incidence With Piperacillin-Tazobactam Vs Cefepime In Adults Hospitalized With Acute Infection
November 30, 2023
Infectious Disease Advisor (11/29, Barowski, RN) reports, “In adults hospitalized with acute infection, piperacillin-tazobactam did not result in higher acute kidney injury incidence but cefepime increased risk for neurologic dysfunction.” The study was p...